Quality Nexgen Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2005.
2005 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Quality Nexgen Pharmaceuticals Private Limited

Quality Nexgen Pharmaceuticals Private Limited, a active private limited company, was established on 16 December 2005 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230MH2005PTC158238. Registered under ROC Roc Mumbai I. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹9.00 M.

It upholds a compliant status. Its leadership includes Shankardayal Ramayan Sharma (Director), Santosh Ramayan Sharma (Director). Past directors included Laxmina Ramayan Sharma, Ramayan Bhirgurasan Sharma, Santosh Ramayan Sharma. It holds ₹8.83 Cr open charges and ₹10.34 Cr settled loans. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at Cts 2116, Plot No. 10/M2, Masterji Compound, Chikuwadi Nr.Malwani Church, Marve Road,, Malad (W), Mumbai, Maharashtra, 400095.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230MH2005PTC158238

  • Registration Number

    158238

  • Incorporation Date

    16 December 2005

  • Authorized Capital

    ₹1.00 Cr

  • Paid-Up Capital

    ₹9.00 M

  • ROC Code

    Roc Mumbai I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 Cr
  • Paid Up Capital ₹ 9.00 M
  • Company Age 20 Year, 6 Months
  • Last Filing with ROC 31 Mar 2022
  • Open Charges ₹ 8.83 Cr
  • Satisfied Charges ₹ 10.34 Cr
  • Revenue Growth **** -17.28%
  • Profit Growth **** 315.55%
  • Ebitda **** 73.91%
  • Net Worth 12.68%
  • Total Assets -12.25%
Company report

Quality Nexgen Pharmaceuticals Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Quality Nexgen Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Quality Nexgen Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Shankardayal Ramayan Sharma Director 01 Mar 2012 Current
Santosh Ramayan Sharma Director 09 Oct 2020 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Whole-Time Director 27 Jul 2011 Past
Pramod Abcsdd Whole-Time Director 09 Oct 2020 Past
Pramod Abcsdd Director 01 Dec 2016 Past
Pramod Abcsdd Additional Director 24 Jan 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Quality Nexgen Pharmaceuticals.

Quality Nexgen Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 17.28% decrease. The company also saw a substantial improvement in profitability, with a 315.55% increase in profit. The company's net worth Soared by an impressive increase of 12.68%.

Quality Nexgen Pharmaceuticals revenue growth over time
Quality Nexgen Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -17.28%
*******
*******
*******
*******
Revenue from Operations
*******
 -17.95%
*******
*******
*******
*******
Total Assets
*******
 -12.25%
*******
*******
*******
*******
Profit or Loss
*******
 315.55%
*******
*******
*******
*******
Net Worth
*******
 12.68%
*******
*******
*******
*******
EBITDA
*******
 73.91%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Quality Nexgen Pharmaceuticals?

In 2020, Quality Nexgen Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹88,260,000.00

Satisfied Charges

₹103,445,839.00

Charges Breakdown by Lending Institutions
  • Axis Bank Limited : 7.58 Cr
  • Capri Global Capital Limited : 1.25 Cr
Latest Charge Details
Date Lender Amount Status
24 Feb 2014 Axis Bank Limited ₹3.68 Cr Open
10 Dec 2013 Axis Bank Limited ₹3.90 Cr Open
31 Jul 2013 Capri Global Capital Limited ₹1.25 Cr Open
30 Jan 2012 The Thane Janata Sahakari Bank Ltd ₹2.30 M Satisfied
24 Dec 2011 The Thane Janata Sahakari Bank Ltd. ₹3.62 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Quality Nexgen Pharmaceuticals?

Unlock and access historical data on people associated with Quality Nexgen Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Quality Nexgen Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Quality Nexgen Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Quality Nexgen Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Quality Nexgen Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Quality Nexgen Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Mumbai I. was completed.

  • Director Appointment

    Santosh Ramayan Sharma was appointed as a Director was appointed as a Director on 09 Oct 2020 & has been associated with this company since 5 years 8 months . was recorded as a recent event.

  • Charges

    A charge registered on 30 Jan 2012 via Charge ID 10338202 with The Thane Janata Sahakari Bank Ltd was fully satisfied on 19 Apr 2018. was recorded as a recent event.

  • Charges

    A charge with Axis Bank Limited of Rs. 3.68 Cr registered on 24 Feb 2014 with Charge ID 10511612 was modified on 20 Jan 2016. was recorded as a recent event.

  • Charges

    A charge with Axis Bank Limited of Rs. 3.90 Cr registered on 10 Dec 2013 with Charge ID 10475723 was modified on 28 Dec 2015. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Quality Nexgen Pharmaceuticals Private Limited?

The CIN of Quality Nexgen Pharmaceuticals Private Limited is U24230MH2005PTC158238.

Where is Quality Nexgen Pharmaceuticals Private Limited headquartered?

Quality Nexgen Pharmaceuticals Private Limited is headquartered at Cts 2116, Plot No. 10/M2, Masterji Compound, Chikuwadi Nr.Malwani Church, Marve Road,, Malad (W), Mumbai, Maharashtra, 400095.

When was Quality Nexgen Pharmaceuticals Private Limited incorporated?

Quality Nexgen Pharmaceuticals Private Limited was incorporated on 16 December 2005.

Who are the current directors of Quality Nexgen Pharmaceuticals Private Limited?

The current directors of Quality Nexgen Pharmaceuticals Private Limited are

What is the primary industry of Quality Nexgen Pharmaceuticals Private Limited?

The primary industry of Quality Nexgen Pharmaceuticals Private Limited is Manufacturing.

Is Quality Nexgen Pharmaceuticals Private Limited a listed company?

Quality Nexgen Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Quality Nexgen Pharmaceuticals Private Limited?

The authorized capital of Quality Nexgen Pharmaceuticals Private Limited is ₹1.00 Cr, and the paid-up capital is ₹9.00 M.

What is the compliance status of Quality Nexgen Pharmaceuticals Private Limited?

The compliance status of Quality Nexgen Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available